Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/106693
DC FieldValueLanguage
dc.contributor.authorCosta, Eduardo-
dc.contributor.authorFerreira-Gonçalves, Tânia-
dc.contributor.authorChasqueira, Gonçalo-
dc.contributor.authorCabrita, António S.-
dc.contributor.authorFigueiredo, Isabel V.-
dc.contributor.authorReis, Catarina Pinto-
dc.date.accessioned2023-04-17T10:05:43Z-
dc.date.available2023-04-17T10:05:43Z-
dc.date.issued2020-
dc.identifier.issn2218-0532pt
dc.identifier.urihttps://hdl.handle.net/10316/106693-
dc.description.abstractBreast cancer is one of the most common cancers worldwide, which makes it a very impactful malignancy in the society. Breast cancers can be classified through di erent systems based on the main tumor features and gene, protein, and cell receptors expression, which will determine the most advisable therapeutic course and expected outcomes. Multiple therapeutic options have already been proposed and implemented for breast cancer treatment. Nonetheless, their use and e cacy still greatly depend on the tumor classification, and treatments are commonly associated with invasiveness, pain, discomfort, severe side e ects, and poor specificity. This has demanded an investment in the research of the mechanisms behind the disease progression, evolution, and associated risk factors, and on novel diagnostic and therapeutic techniques. However, advances in the understanding and assessment of breast cancer are dependent on the ability to mimic the properties and microenvironment of tumors in vivo, which can be achieved through experimentation on animal models. This review covers an overview of the main animal models used in breast cancer research, namely in vitro models, in vivo models, in silico models, and other models. For each model, the main characteristics, advantages, and challenges associated to their use are highlighted.pt
dc.language.isoengpt
dc.publisherMDPIpt
dc.relationUID/DTP/04138/2019pt
dc.relationUIDB/00313/2020pt
dc.relationSFRH/BD/147306/2019pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectoncologypt
dc.subjectbreast cancerpt
dc.subjectexperimental modelspt
dc.subjectanimal modelspt
dc.subjectin vitropt
dc.subjectin silicopt
dc.subjectpharmacological testingpt
dc.subjectstrategies of drug developmentpt
dc.titleExperimental Models as Refined Translational Tools for Breast Cancer Researchpt
dc.typearticle-
degois.publication.firstPage32pt
degois.publication.issue3pt
degois.publication.titleScientia Pharmaceuticapt
dc.peerreviewedyespt
dc.identifier.doi10.3390/scipharm88030032pt
degois.publication.volume88pt
dc.date.embargo2020-01-01*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
crisitem.author.deptFaculty of Medicine-
crisitem.author.parentdeptUniversity of Coimbra-
crisitem.author.orcid0000-0002-2295-5532-
Appears in Collections:FMUC Medicina - Artigos em Revistas Internacionais
Show simple item record

SCOPUSTM   
Citations

15
checked on May 6, 2024

WEB OF SCIENCETM
Citations

11
checked on May 2, 2024

Page view(s)

52
checked on May 7, 2024

Download(s)

18
checked on May 7, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons